Individuals with narcolepsy type 1 (NT1) have reduced levels of pathological proteins such as Aβ, tau, and phosphorylated-tau in their CSF, and decreased amyloid deposition on positron emission tomography scans29. The gene discussed is MAPT; the disease is narcolepsy-cataplexy syndrome.